From: Development and application of a biomarker assay for determining the pharmacodynamic activity of an antagonist candidate biotherapeutic antibody to IL21R in whole blood
Gene
Average Fold Change (with IL21)
SD
P-value paired t-test
IL2RA
4.1
1.76
< 0.0001
PRF1
1.8
0.78
<0.0001
IL21R
2.3
0.63
GZMB
1.6
0.39
IL6
2.7
1.72
0.0007